The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
CHAI started supporting Indonesia’s Ministry of Health in 2010 to scale up adult anti-retroviral therapy, through improving supply chain management; as well as technical assistance for improving the quality of ART and laboratory systems to support HIV care and treatment. In recent years, CHAI has expanded its support to the Ministry of Health to other areas including hepatitis and helping to facilitate BMS to and donate pan genotyping DAA, daclatasvir, more effective treatment for HCV patient, improving access to family planning, point of care diagnostics, m-health, maternal and child health, and technical support for the Ministry of Health’s drive to sustainably fund healthcare. In mid-2016, CHAI launched its vaccines program to introduce new vaccine introduction, PCV, to EPI, Ministry of Health Indonesia, The focus of the program is to support the EPI in new vaccine introductions, assisting the government to make an-informed and coordinated decision on PCV introduction.
Overview of the CHAI Indonesia Cancer Paediatric Work
Paediatric Cancer remains an increasing challenges with only 20-30% of survival children in low and middle income countries, compared to more than 80% in high-income countries. The inequity to care access, late diagnosis & treatment and high treatment abandonment are common in paediatric cancer medication. In Indonesia, WHO-IARC estimates that 7,574 children under the age of 14 developed cancer in 2020, with the majority being leukaemia cases (30%). Despite Indonesia having developed a population based cancer registry in 14 provinces since 2016, only about 10 hospital centers have hospital based paediatric cancer registry, and the coverage and data quality remain low, meaning many paediatric cancer cases are unreported. This disparity in paediatric cancer is unacceptable considering that most childhood cancers can be effectively treated with affordable, generic medicines, even if they are detected late. This huge outcomes disparity indicates that there is a significant opportunity to save lives if treatment access can be improved.
Position Description Program Manager Paediatric Cancer
CHAI is looking for a dynamic, energetic individual with exceptional people skills, highly qualified with experience in Paediatric Cancer or related non-communicable diseases field and experienced in working in challenging environments to support its Indonesia Ca Ped program. This is a very demanding post, which will prove to be very rewarding for the right candidate.
CHAI’s proposed work will be focused on strategic goals:
The Program Manager (PM) will lead efforts to deliver the objectives of the paediatric cancer program, under the guidance and direction of the Senior Program Manager (SPM) and or Program Director (PD) and direct reporting to the SPM. He/She will provide both strategic and technical direction for the program, overseeing its development and assuming responsibility for high quality delivery. PM will maintain the relationship and communication with key stakeholders, including hospital centers, NCD of MoH, provincial & district health offices, paediatrics collegium/expert panels, paediatric cancer foundations, along with relevant Program Officers (POs). In coordination with SPM and or PD, PM will also work closely with relevant CHAI’s Global team, other CHAI Country PMs, other international partners, and other national stakeholders.